Research progress on classical traditional chinese medicine formula xiaoyaosan in the treatment of depression

被引:38
作者
Chen, Jianbei [1 ]
Lei, Chaofang [1 ]
Li, Xiaojuan [2 ]
Wu, Qian [1 ]
Liu, Chenyue [3 ]
Ma, Qingyu [2 ]
Chen, Jiaxu [1 ,2 ]
机构
[1] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing, Peoples R China
[2] Jinan Univ, Formula pattern Res Ctr, Sch Tradit Chinese Med, Guangzhou, Peoples R China
[3] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
xiaoyaosan; TCM; depression; clinical application; pharmacological mechanism; research progress; review; CHRONIC IMMOBILIZATION STRESS; NEUROTROPHIC FACTOR; HIPPOCAMPAL NEUROGENESIS; FUNCTIONAL DYSPEPSIA; ADJUVANT TREATMENT; MAJOR DEPRESSION; LIVER-DEPRESSION; GUT MICROBIOTA; MESSENGER-RNA; NMDA RECEPTOR;
D O I
10.3389/fphar.2022.925514
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Depression is an emotional disorder that is problematic in psychiatry owing to its unclear etiology and unknown pathogenesis. Traditional Chinese medicine formulations such as Xiaoyaosan have been widely used throughout history to treat depression. In this review, we have focused on recent evidences elucidating the links between Xiaoyaosan and the treatment of depression. Data from animal and clinical studies, focusing on the pharmacological mechanisms, clinical applications, and effective materials that form the basis for the treatment of depression are presented and discussed. We found that the antidepressant effects of Xiaoyaosan are related to the effects of monoamine neurotransmitters, regulation of the hypothalamic-pituitary-adrenal axis, neuroplasticity, synaptic plasticity, inflammatory response, neuroprotection, brain-gut axis, regulation of intestinal microbiota, oxidative stress, and autophagy for reducing neuronal apoptosis. This review highlights the current evidence supporting the use of Xiaoyaosan as an antidepressant and provides an overview of the potential mechanisms involved.
引用
收藏
页数:19
相关论文
共 125 条
  • [1] Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder
    Aizawa, Emiko
    Tsuji, Hirokazu
    Asahara, Takashi
    Takahashi, Takuya
    Teraishi, Toshiya
    Yoshida, Sumiko
    Ota, Miho
    Koga, Norie
    Hattori, Kotaro
    Kunugi, Hiroshi
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2016, 202 : 254 - 257
  • [2] Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
    Aleksandrova, Lily R.
    Phillips, Anthony G.
    Wang, Yu Tian
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2017, 42 (04): : 222 - 229
  • [3] Ao H, 2006, PROPR CHIN MED, V28, P697, DOI [10.3969/j.issn.1001-1528.2006.05.0, DOI 10.3969/J.ISSN.1001-1528.2006.05.0]
  • [4] Appleton Jeremy, 2018, Integr Med (Encinitas), V17, P28
  • [5] Balu DT, 2016, ADV PHARMACOL, V76, P351, DOI 10.1016/bs.apha.2016.01.006
  • [6] Bao Li, 2008, Zhong Yao Cai, V31, P1360
  • [7] Brain-derived neurotrophic factor and its clinical implications
    Bathina, Siresha
    Das, Undurti N.
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (06) : 1164 - 1178
  • [8] Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis
    Cai, Li
    Li, Rong
    Tang, Wen-jian
    Meng, Gang
    Hu, Xiang-yang
    Wu, Ting-ni
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (08) : 1332 - 1341
  • [9] Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients
    Carpenter, LL
    Moreno, FA
    Kling, MA
    Anderson, GM
    Regenold, WT
    Labiner, DM
    Price, LH
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 56 (06) : 418 - 426
  • [10] Opinion -: Is mood chemistry?
    Castrén, E
    [J]. NATURE REVIEWS NEUROSCIENCE, 2005, 6 (03) : 241 - 246